Article
Advances and challenges for hemophilia gene therapy
19 Jul 2019
Abstract excerpt
Hemophilia is an X-linked inherited bleeding disorder, resulting from defects in the F8 (hemophilia A) or F9 (hemophilia B) genes. Persons with hemophilia have bleeding episodes into the soft tissues and joints, which are treated with self-infusion of factor VIII or IX concentrates. Hemophilia provides an attractive target for gene therapy studies, due to the monogenic nature of these disorders and easily...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
